Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2000
12/28/2000WO2000054780A3 Corticosteroid formulation
12/28/2000WO2000053767A3 Nucleic acid respiratory syncytial virus vaccines
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000WO2000031093A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/28/2000WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors
12/28/2000DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2377524A1 Novel anti-allergic agents
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375282A1 Potassium channel openers
12/28/2000CA2375229A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000CA2375211A1 Antiviral agents
12/28/2000CA2373497A1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
12/28/2000CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
12/27/2000EP1062236A1 31 human secreted proteins
12/27/2000EP1062222A1 Serine peptidase modulators
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062216A1 Inhibitors of phospholipase a2
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062209A1 Metabolically inert anti-inflammatory and anti-tumor antifolates
12/27/2000EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1061926A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
12/27/2000EP1061911A2 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
12/27/2000EP1061910A1 Use of alpha-rar antagonists for inhibition of mucin secretion
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1277870A Traditional Chinese medicine (Xianqi) mixture for treating chronic bronchitis
12/27/2000CN1277866A Patent medicine contg. triditional Chinese medicine and western medicine for treating cough and asthma disease
12/27/2000CN1277843A Compound medicinal prepn. for treating acute and chronic nasosinusitis, rhinitis and tympanitis
12/27/2000CN1277841A Quick absorption liquid composite
12/27/2000CN1059905C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
12/27/2000CN1059834C Pure traditional Chinese medicinal liquor with antisenile action
12/27/2000CN1059812C Chinese medicine for treating tracheitis
12/26/2000US6166206 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166031 An inhibitor of 5-lipoxygenase enzyme, a blocking agents of leukotriene receptors; useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction
12/26/2000US6166023 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
12/26/2000US6166022 Treatment of platelet aggregation disorders and angina
12/26/2000US6166015 Pyrrolidine derivatives-CCR-3 receptor antagonists
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
12/26/2000US6165771 Compounds
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165445 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077246A2 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
12/21/2000WO2000076587A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000WO2000076541A1 Pneumococcal surface protein combination vaccine
12/21/2000WO2000076535A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076500A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction
12/21/2000WO2000076478A1 Controlled release and taste masking oral pharmaceutical compositions
12/21/2000WO2000076474A1 Acidic buffered nasal spray
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000WO2000031094A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2379327A1 Pneumococcal surface protein combination vaccine
12/21/2000CA2377431A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods
12/21/2000CA2372558A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060173A2 Benzazine derivatives phosphodiesterase 4 inhibitors
1 ... 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 ... 878